ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data

  New, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.

• Evaluating Wearable Data Platforms For Endpoint-Driven Studies

  Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.

• An Expert's View On Choosing And Developing An eCOA Strategy

  Dive into the insights from our recent LinkedIn Live discussion where we explored how a standardized approach to eCOA could transform clinical trials and streamline data collection.

• Case Study: Using Technology To Reduce Operational Burden In Clinical Research

  The Beat AML® master trial is transforming treatment for people with acute myeloid leukemia (AML), already improving survival for patients enrolled in a Beat AML study vs. standard chemotherapy. Read this case study to learn how a proven EHR-to-EDC system has enabled the success of this impactful trial.

• Introducing Digitally-Enabled Biosample Consent Storage

  Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.

• The Future Of Wearable Technology In Clinical Trials

  Learn how wearable technology is reshaping the future of clinical trials, offering opportunities to collect continuous, real-time health data while improving patient access and engagement.

• Study, Not Software: Aligning RTSM To The Protocol

  How can RTSM platforms improve your clinical trial and how do they integrate with your crucial trial systems?

• Building Blocks: The Ultimate Guide To AI In Clinical Trials

  This comprehensive guide provides an authoritative, in-depth look at AI's role in accelerating drug development and improving patient outcomes, with special focus on emerging agentic AI technologies.

• How DCTs Became The New Standard

  See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

• Why Scalable EDC Systems Matter In Global Pharmaceutical Trials

  Sponsors who treat EDC as core infrastructure—not just software—are best positioned to succeed globally. Explore how EDC platforms keep studies compliant while enabling flexibility.